EntryPoint Capital LLC acquired a new position in Viemed Healthcare, Inc. (NASDAQ:VMD – Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 11,474 shares of the company’s stock, valued at approximately $92,000.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Martingale Asset Management L P increased its position in shares of Viemed Healthcare by 28.5% during the third quarter. Martingale Asset Management L P now owns 31,385 shares of the company’s stock valued at $230,000 after acquiring an additional 6,965 shares during the last quarter. Walleye Capital LLC purchased a new position in shares of Viemed Healthcare during the 3rd quarter worth approximately $87,000. PDT Partners LLC acquired a new stake in Viemed Healthcare in the 3rd quarter valued at approximately $78,000. Wasatch Advisors LP raised its position in Viemed Healthcare by 19.6% in the third quarter. Wasatch Advisors LP now owns 1,848,884 shares of the company’s stock valued at $13,552,000 after purchasing an additional 303,277 shares during the period. Finally, National Bank of Canada FI lifted its stake in Viemed Healthcare by 91.2% during the third quarter. National Bank of Canada FI now owns 3,346 shares of the company’s stock worth $25,000 after purchasing an additional 1,596 shares in the last quarter. Institutional investors and hedge funds own 74.24% of the company’s stock.
Viemed Healthcare Trading Up 0.3 %
Shares of NASDAQ VMD opened at $7.27 on Monday. The company has a current ratio of 1.31, a quick ratio of 1.19 and a debt-to-equity ratio of 0.03. The stock has a market capitalization of $287.32 million, a PE ratio of 26.93 and a beta of 1.50. Viemed Healthcare, Inc. has a twelve month low of $6.21 and a twelve month high of $9.81. The stock has a fifty day simple moving average of $7.82 and a 200-day simple moving average of $8.19.
Viemed Healthcare Company Profile
Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.
Featured Stories
- Five stocks we like better than Viemed Healthcare
- What Are Treasury Bonds?
- Venezuelan Tariffs Could Power These 3 Diesel-Driven Winners
- Financial Services Stocks Investing
- MarketBeat Week in Review – 03/24 – 03/28
- Stock Splits, Do They Really Impact Investors?
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
Want to see what other hedge funds are holding VMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Viemed Healthcare, Inc. (NASDAQ:VMD – Free Report).
Receive News & Ratings for Viemed Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viemed Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.